Financial - Data & Stock Exchanges
Compare Stocks
5 / 10Stock Comparison
SPGI vs MCO vs ICE vs FDS vs CME
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
SPGI vs MCO vs ICE vs FDS vs CME — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges |
| Market Cap | $126.89B | $81.04B | $88.45B | $9.63B | $104.07B |
| Revenue (TTM) | $15.34B | $7.72B | $12.64B | $2.32B | $6.52B |
| Net Income (TTM) | $4.78B | $2.50B | $3.30B | $600M | $4.24B |
| Gross Margin | 70.2% | 68.2% | 61.9% | 52.7% | 86.1% |
| Operating Margin | 42.2% | 44.8% | 38.7% | 32.2% | 64.9% |
| Forward P/E | 21.8x | 27.4x | 19.5x | 12.6x | 23.5x |
| Total Debt | $14.20B | $7.35B | $20.28B | $1.56B | $3.76B |
| Cash & Equiv. | $1.75B | $2.38B | $837M | $338M | $4.42B |
SPGI vs MCO vs ICE vs FDS vs CME — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| S&P Global Inc. (SPGI) | 100 | 131.9 | +31.9% |
| Moody's Corporation (MCO) | 100 | 170.9 | +70.9% |
| Intercontinental Ex… (ICE) | 100 | 160.6 | +60.6% |
| FactSet Research Sy… (FDS) | 100 | 72.8 | -27.2% |
| CME Group Inc. (CME) | 100 | 157.1 | +57.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SPGI vs MCO vs ICE vs FDS vs CME
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, SPGI doesn't own a clear edge in any measured category.
MCO ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 8.9%, EPS growth 21.4%
- 409.5% 10Y total return vs CME's 284.9%
- 8.9% NII/revenue growth vs FDS's 5.4%
ICE is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.33, Low D/E 69.9%, current ratio 1.02x
- Beta 0.33 vs MCO's 0.86, lower leverage
FDS carries the broadest edge in this set and is the clearest fit for income & stability and valuation efficiency.
- Dividend streak 21 yrs, beta 0.43, yield 1.9%
- PEG 1.26 vs MCO's 3.51
- Beta 0.43, yield 1.9%, current ratio 1.40x
- Lower P/E (12.6x vs 23.5x), PEG 1.26 vs 1.71
CME is the #2 pick in this set and the best alternative if dividends and momentum is your priority.
- 3.8% yield, 6-year raise streak, vs MCO's 0.9%
- +4.6% vs FDS's -48.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.9% NII/revenue growth vs FDS's 5.4% | |
| Value | Lower P/E (12.6x vs 23.5x), PEG 1.26 vs 1.71 | |
| Quality / Margins | Efficiency ratio 0.2% vs SPGI's 0.3% (lower = leaner) | |
| Stability / Safety | Beta 0.33 vs MCO's 0.86, lower leverage | |
| Dividends | 3.8% yield, 6-year raise streak, vs MCO's 0.9% | |
| Momentum (1Y) | +4.6% vs FDS's -48.1% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs SPGI's 0.3% |
SPGI vs MCO vs ICE vs FDS vs CME — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SPGI vs MCO vs ICE vs FDS vs CME — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CME leads in 3 of 6 categories
FDS leads 1 • MCO leads 1 • SPGI leads 0 • ICE leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CME leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
SPGI is the larger business by revenue, generating $15.3B annually — 6.6x FDS's $2.3B. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to FDS's 25.7%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $15.3B | $7.7B | $12.6B | $2.3B | $6.5B |
| EBITDAEarnings before interest/tax | $7.8B | $4.0B | $6.5B | $947M | $4.7B |
| Net IncomeAfter-tax profit | $4.8B | $2.5B | $3.3B | $600M | $4.2B |
| Free Cash FlowCash after capex | $5.6B | $3.0B | $4.3B | $647M | $4.4B |
| Gross MarginGross profit ÷ Revenue | +70.2% | +68.2% | +61.9% | +52.7% | +86.1% |
| Operating MarginEBIT ÷ Revenue | +42.2% | +44.8% | +38.7% | +32.2% | +64.9% |
| Net MarginNet income ÷ Revenue | +29.2% | +31.9% | +26.1% | +25.7% | +62.0% |
| FCF MarginFCF ÷ Revenue | +35.6% | +33.4% | +33.9% | +26.6% | +64.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +32.5% | +7.8% | +23.1% | +4.4% | +21.4% |
Valuation Metrics
FDS leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 14.4x trailing earnings, FDS trades at a 57% valuation discount to MCO's 33.4x P/E. Adjusting for growth (PEG ratio), FDS offers better value at 1.44x vs MCO's 4.29x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $126.9B | $81.0B | $88.4B | $9.6B | $104.1B |
| Enterprise ValueMkt cap + debt − cash | $139.3B | $86.0B | $107.9B | $10.9B | $103.4B |
| Trailing P/EPrice ÷ TTM EPS | 29.24x | 33.44x | 27.06x | 14.40x | 25.70x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.84x | 27.37x | 19.48x | 12.62x | 23.49x |
| PEG RatioP/E ÷ EPS growth rate | 3.36x | 4.29x | 3.05x | 1.44x | 1.87x |
| EV / EBITDAEnterprise value multiple | 18.20x | 21.86x | 16.71x | 11.59x | 22.96x |
| Price / SalesMarket cap ÷ Revenue | 8.27x | 10.50x | 7.00x | 4.15x | 15.96x |
| Price / BookPrice ÷ Book value/share | 3.62x | 19.56x | 3.08x | 3.93x | 3.60x |
| Price / FCFMarket cap ÷ FCF | 23.26x | 31.47x | 20.62x | 15.60x | 24.82x |
Profitability & Efficiency
MCO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MCO delivers a 64.1% return on equity — every $100 of shareholder capital generates $64 in annual profit, vs $12 for ICE. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to MCO's 1.75x. On the Piotroski fundamental quality scale (0–9), MCO scores 9/9 vs CME's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.9% | +64.1% | +11.6% | +27.7% | +15.3% |
| ROA (TTM)Return on assets | +7.9% | +16.2% | +2.3% | +14.2% | +2.2% |
| ROICReturn on invested capital | +9.7% | +22.5% | +7.5% | +15.5% | +10.2% |
| ROCEReturn on capital employed | +12.1% | +27.9% | +9.5% | +20.9% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 9 | 9 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.39x | 1.75x | 0.70x | 0.71x | 0.13x |
| Net DebtTotal debt minus cash | $12.5B | $5.0B | $19.4B | $1.2B | -$666M |
| Cash & Equiv.Liquid assets | $1.7B | $2.4B | $837M | $338M | $4.4B |
| Total DebtShort + long-term debt | $14.2B | $7.4B | $20.3B | $1.6B | $3.8B |
| Interest CoverageEBIT ÷ Interest expense | 22.69x | 17.22x | 6.53x | 14.22x | 41.55x |
Total Returns (Dividends Reinvested)
CME leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CME five years ago would be worth $16,450 today (with dividends reinvested), compared to $7,219 for FDS. Over the past 12 months, CME leads with a +4.6% total return vs FDS's -48.1%. The 3-year compound annual growth rate (CAGR) favors CME at 19.7% vs FDS's -16.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.2% | -8.2% | -2.1% | -21.0% | +9.1% |
| 1-Year ReturnPast 12 months | -14.5% | -1.5% | -10.4% | -48.1% | +4.6% |
| 3-Year ReturnCumulative with dividends | +23.8% | +52.8% | +50.8% | -41.3% | +71.4% |
| 5-Year ReturnCumulative with dividends | +14.2% | +41.4% | +43.4% | -27.8% | +64.5% |
| 10-Year ReturnCumulative with dividends | +337.1% | +409.5% | +225.3% | +68.6% | +284.9% |
| CAGR (3Y)Annualised 3-year return | +7.4% | +15.2% | +14.7% | -16.3% | +19.7% |
Risk & Volatility
CME leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than MCO's 0.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CME currently trades 87.1% from its 52-week high vs FDS's 47.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.58x | 0.86x | 0.33x | 0.43x | -0.30x |
| 52-Week HighHighest price in past year | $579.05 | $546.88 | $189.35 | $474.79 | $329.16 |
| 52-Week LowLowest price in past year | $381.61 | $402.28 | $143.17 | $189.07 | $257.17 |
| % of 52W HighCurrent price vs 52-week peak | +74.0% | +83.6% | +82.5% | +47.2% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 42.4 | 48.0 | 38.8 | 39.7 | 44.1 |
| Avg Volume (50D)Average daily shares traded | 1.8M | 1.1M | 3.0M | 908K | 2.2M |
Analyst Outlook
Evenly matched — MCO and CME each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SPGI as "Buy", MCO as "Buy", ICE as "Buy", FDS as "Hold", CME as "Hold". Consensus price targets imply 27.9% upside for SPGI (target: $548) vs 11.6% for CME (target: $320). For income investors, CME offers the higher dividend yield at 3.81% vs MCO's 0.85%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $548.11 | $544.75 | $195.71 | $277.89 | $320.25 |
| # AnalystsCovering analysts | 28 | 32 | 36 | 28 | 35 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +0.9% | +1.2% | +1.9% | +3.8% |
| Dividend StreakConsecutive years of raises | 12 | 22 | 14 | 21 | 6 |
| Dividend / ShareAnnual DPS | $3.83 | $3.90 | $1.93 | $4.17 | $10.92 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.9% | +2.1% | +1.6% | +3.1% | +0.3% |
CME leads in 3 of 6 categories (Income & Cash Flow, Total Returns). FDS leads in 1 (Valuation Metrics). 1 tied.
SPGI vs MCO vs ICE vs FDS vs CME: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SPGI or MCO or ICE or FDS or CME a better buy right now?
For growth investors, Moody's Corporation (MCO) is the stronger pick with 8.
9% revenue growth year-over-year, versus 5. 4% for FactSet Research Systems Inc. (FDS). FactSet Research Systems Inc. (FDS) offers the better valuation at 14. 4x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate S&P Global Inc. (SPGI) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SPGI or MCO or ICE or FDS or CME?
On trailing P/E, FactSet Research Systems Inc.
(FDS) is the cheapest at 14. 4x versus Moody's Corporation at 33. 4x. On forward P/E, FactSet Research Systems Inc. is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: FactSet Research Systems Inc. wins at 1. 26x versus Moody's Corporation's 3. 51x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — SPGI or MCO or ICE or FDS or CME?
Over the past 5 years, CME Group Inc.
(CME) delivered a total return of +64. 5%, compared to -27. 8% for FactSet Research Systems Inc. (FDS). Over 10 years, the gap is even starker: MCO returned +409. 5% versus FDS's +68. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SPGI or MCO or ICE or FDS or CME?
By beta (market sensitivity over 5 years), CME Group Inc.
(CME) is the lower-risk stock at -0. 30β versus Moody's Corporation's 0. 86β — meaning MCO is approximately -384% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 175% for Moody's Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — SPGI or MCO or ICE or FDS or CME?
By revenue growth (latest reported year), Moody's Corporation (MCO) is pulling ahead at 8.
9% versus 5. 4% for FactSet Research Systems Inc. (FDS). On earnings-per-share growth, the picture is similar: Moody's Corporation grew EPS 21. 4% year-over-year, compared to 11. 8% for FactSet Research Systems Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SPGI or MCO or ICE or FDS or CME?
CME Group Inc.
(CME) is the more profitable company, earning 62. 0% net margin versus 25. 7% for FactSet Research Systems Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 32. 2% for FDS. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SPGI or MCO or ICE or FDS or CME more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, FactSet Research Systems Inc. (FDS) is the more undervalued stock at a PEG of 1. 26x versus Moody's Corporation's 3. 51x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, FactSet Research Systems Inc. (FDS) trades at 12. 6x forward P/E versus 27. 4x for Moody's Corporation — 14. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SPGI: 27. 9% to $548. 11.
08Which pays a better dividend — SPGI or MCO or ICE or FDS or CME?
All stocks in this comparison pay dividends.
CME Group Inc. (CME) offers the highest yield at 3. 8%, versus 0. 9% for Moody's Corporation (MCO).
09Is SPGI or MCO or ICE or FDS or CME better for a retirement portfolio?
For long-horizon retirement investors, CME Group Inc.
(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +284. 9% 10Y return). Both have compounded well over 10 years (CME: +284. 9%, MCO: +409. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SPGI and MCO and ICE and FDS and CME?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SPGI is a mid-cap quality compounder stock; MCO is a mid-cap quality compounder stock; ICE is a mid-cap quality compounder stock; FDS is a small-cap deep-value stock; CME is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.